Schroder Investment Management Group Exelixis, Inc. Transaction History

Schroder Investment Management Group

$112 Billion
Q2 2025

A detailed history of Schroder Investment Management Group transactions in Exelixis, Inc. stock. As of the latest transaction made, Schroder Investment Management Group holds 841,624 shares of EXEL stock, worth $32.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

841,624

Previous 707,677 18.93%

Holding current value

$32.5 Million

Previous $26.1 Million 41.99%

% of portfolio

0.03%

Previous 0.03%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$34.13 - $46.26 $4.57 Million - $6.2 Million	133,947 Added 18.93%	841,624 $37.1 Million
Q1 2025 May 13, 2025	BUY	$32.38 - $39.16 $4.82 Million - $5.83 Million	148,879 Added 26.64%	707,677 $26.1 Million
Q4 2024 Feb 12, 2025	BUY	$25.39 - $36.46 $6.63 Million - $9.51 Million	260,940 Added 87.61%	558,798 $18.6 Million
Q3 2024 Nov 13, 2024	BUY	$21.96 - $27.6 $6.54 Million - $8.22 Million	297,858 New	297,858 $7.73 Million
Q1 2022 May 16, 2022	SELL	$17.03 - $22.67 $4,121 - $5,486	-242 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$15.84 - $21.88 $1,584 - $2,188	100 Added 70.42%	242 $4,000
Q2 2021 Aug 13, 2021	SELL	$17.95 - $25.56 $4,792 - $6,824	-267 Reduced 65.28%	142 $3,000
Q1 2021 May 17, 2021	BUY	$20.53 - $25.22 $8,396 - $10,314	409 New	409 $9,000
Q3 2020 Nov 13, 2020	SELL	$20.67 - $26.94 $4.29 Million - $5.59 Million	-207,432 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$16.46 - $27.42 $3.14 Million - $5.23 Million	190,716 Added 1140.92%	207,432 $4.92 Million
Q1 2020 May 15, 2020	SELL	$14.46 - $21.8 $38,781 - $58,467	-2,682 Reduced 13.83%	16,716 $295,000
Q4 2019 Feb 11, 2020	BUY	$15.15 - $18.89 $68,099 - $84,910	4,495 Added 30.16%	19,398 $342,000
Q3 2019 Nov 12, 2019	BUY	$17.68 - $22.65 $48,372 - $61,970	2,736 Added 22.49%	14,903 $268,000
Q2 2019 Aug 08, 2019	SELL	$18.93 - $24.75 $153,503 - $200,697	-8,109 Reduced 39.99%	12,167 $260,000
Q1 2019 May 14, 2019	BUY	$19.6 - $24.76 $4,527 - $5,719	231 Added 1.15%	20,276 $483,000
Q4 2018 Feb 14, 2019	SELL	$13.65 - $21.8 $253,753 - $405,262	-18,590 Reduced 48.12%	20,045 $394,000
Q3 2018 Nov 13, 2018	BUY	$15.87 - $22.4 $613,137 - $865,424	38,635 New	38,635 $685,000
Q2 2018 Aug 13, 2018	SELL	$18.56 - $22.45 $516,227 - $624,424	-27,814 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$22.15 - $31.89 $149,866 - $215,767	6,766 Added 32.15%	27,814 $616,000
Q4 2017 Feb 09, 2018	BUY	$24.23 - $30.93 $175,982 - $224,644	7,263 Added 52.69%	21,048 $640,000
Q3 2017 Nov 09, 2017	BUY	$23.35 - $29.24 $321,879 - $403,073	13,785	13,785 $334,000

Others Institutions Holding EXEL

# of Institutions

697

Shares Held

259M

Call Options Held

1.41M

Put Options Held

1.55M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $12.4B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.

Account

Schroder Investment Management Group Exelixis, Inc. Transaction History